Literature DB >> 33962052

Clinically Responsive Genomic Analysis Pipelines: Elements to Improve Detection Rate and Efficiency.

Samantha Leigh Sundercombe1, Marina Berbic2, Carey-Anne Evans3, Corrina Cliffe4, George Elakis4, Suzanna E L Temple5, Arthavan Selvanathan6, Lisa Ewans7, Nila Quayum4, Cheng-Yee Nixon8, Kerith-Rae Dias9, Sarah Lang4, Anna Richards4, Shuxiang Goh8, Meredith Wilson10, David Mowat11, Rani Sachdev11, Sarah Sandaradura10, Maie Walsh12, Michelle A Farrar13, Rebecca Walsh4, Janice Fletcher4, Edwin P Kirk14, Guus M Teunisse3, Deborah Schofield15, Michael Francis Buckley4, Ying Zhu16, Tony Roscioli17.   

Abstract

Massively parallel sequencing has markedly improved mendelian diagnostic rates. This study assessed the effects of custom alterations to a diagnostic genomic bioinformatic pipeline in response to clinical need and derived practice recommendations relative to diagnostic rates and efficiency. The Genomic Annotation and Interpretation Application (GAIA) bioinformatics pipeline was designed to detect panel, exome, and genome sample integrity and prioritize gene variants in mendelian disorders. Reanalysis of selected negative cases was performed after improvements to the pipeline. GAIA improvements and their effect on sensitivity are described, including addition of a PubMed search for gene-disease associations not in the Online Mendelian Inheritance of Man database, inclusion of a process for calling low-quality variants (known as QPatch), and gene symbol nomenclature consistency checking. The new pipeline increased the diagnostic rate and reduced staff costs, resulting in a saving of US$844.34 per additional diagnosis. Recommendations for genomic analysis pipeline requirements are summarized. Clinically responsive bioinformatics pipeline improvements increase diagnostic sensitivity and increase cost-effectiveness. Crown
Copyright © 2021. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33962052     DOI: 10.1016/j.jmoldx.2021.04.007

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  2 in total

1.  Neonatal-lethal dilated cardiomyopathy due to a homozygous LMOD2 donor splice-site variant.

Authors:  Michaela Yuen; Lisa Worgan; Jessika Iwanski; Christopher T Pappas; Himanshu Joshi; Jared M Churko; Susan Arbuckle; Edwin P Kirk; Ying Zhu; Tony Roscioli; Carol C Gregorio; Sandra T Cooper
Journal:  Eur J Hum Genet       Date:  2022-01-26       Impact factor: 4.246

2.  Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.

Authors:  Marcel E Dinger; Tony Roscioli; Lisa J Ewans; Andre E Minoche; Deborah Schofield; Rupendra Shrestha; Clare Puttick; Ying Zhu; Alexander Drew; Velimir Gayevskiy; George Elakis; Corrina Walsh; Lesley C Adès; Alison Colley; Carolyn Ellaway; Carey-Anne Evans; Mary-Louise Freckmann; Linda Goodwin; Anna Hackett; Benjamin Kamien; Edwin P Kirk; Michelle Lipke; David Mowat; Elizabeth Palmer; Sulekha Rajagopalan; Anne Ronan; Rani Sachdev; William Stevenson; Anne Turner; Meredith Wilson; Lisa Worgan; Marie-Christine Morel-Kopp; Michael Field; Michael F Buckley; Mark J Cowley
Journal:  Eur J Hum Genet       Date:  2022-08-15       Impact factor: 5.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.